EUROPEAN COMMISSION
Brussels, 27.4.2023
COM(2023) 222 final
ANNEX
to the
Proposal for a Regulation of the European Parliament and of the Council
on the unitary supplementary certificate for medicinal products, and amending Regulation (EU) 2017/1001, Regulation (EC) No 1901/2006 as well as Regulation (EU) No 608/2013
{SEC(2023) 172 final} - {SWD(2023) 117 final} - {SWD(2023) 118 final} - {SWD(2023) 119 final}
ANNEX II
Standard form for notification pursuant to Article 5(3), points (b) and (c).
|
Tick the appropriate box |
□ New notification □ Update of an existing notification |
|
|
(a)Name and address of the maker |
… |
|
|
(b)Purpose of making |
□ Export □ Storing □ Export and storing |
|
|
(c)Member State in which making is to take place and Member State in which first related act (if any) prior to making is to take place |
Member State of making |
|
|
(d) |
(Member State of first related act (if any)) |
|
|
(e)Number of unitary certificate having effect in the Member State of making and number of certificate granted in Member State of first related act (if any) prior to making |
Unitary certificate having effect in the Member State of making |
|
|
(Certificate of Member State of first related act (if any)) |
||
|
(f)For medicinal products to be exported to third countries, reference number of marketing authorisation, or the equivalent of such authorisation, in each third country of export |
||
|
(g) |
||
|
(h) |
||